Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Babao Dan for prevention and treatment of minimal hepatic encephalopathy
ChiCTR-IPR-16009578Phase 4Recruiting
- Sponsor
- Shuguang Hospital
- Start
- May 2016
- Countries
- 1
01
Overview
Phase 4 trial of Babaodan in hepatic encephalopathy (HE) and Cirrhosis (3 arms), sponsored by Shuguang Hospital. Primary endpoint: Genomics. Started May 2016; status: recruiting.
02
Drugs
Babaodan
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-IPR-16009578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009578.